Assessing the clinical outcome of nab-paclitaxel in Chinese patients with advanced non-small-cell lung cancer.

about

The role of weekly nanoparticle albumin bound paclitaxel monotherapy as second line or later treatment for advanced NSCLC in China.Nab-paclitaxel as second-line treatment in advanced gastric cancer: a multicenter phase II study of the Hellenic Oncology Research Group.

P2860

Q47100701-0B9A5E34-3B0A-4A91-9611-026DE19CBD1C Q49657442-B5DF8A17-05BF-413A-AA8B-5E787B81B188

P2860

Assessing the clinical outcome of nab-paclitaxel in Chinese patients with advanced non-small-cell lung cancer.

Item

http://www.wikidata.org/entity/Q51591928

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Assessing the clinical outcome ...... ed non-small-cell lung cancer.

@en

Assessing the clinical outcome ...... ed non-small-cell lung cancer.

@nl

type

Item

label

Assessing the clinical outcome ...... ed non-small-cell lung cancer.

@en

Assessing the clinical outcome ...... ed non-small-cell lung cancer.

@nl

prefLabel

Assessing the clinical outcome ...... ed non-small-cell lung cancer.

@en

Assessing the clinical outcome ...... ed non-small-cell lung cancer.

@nl

P1476

Assessing the clinical outcome ...... ed non-small-cell lung cancer.

@en

P2093

Dongmei Yuan

http://www.w3.org/2001/XMLSchema#string

Guannan Wu

http://www.w3.org/2001/XMLSchema#string

Jie Yin

http://www.w3.org/2001/XMLSchema#string

Junli Zeng

http://www.w3.org/2001/XMLSchema#string

Wen Yang

http://www.w3.org/2001/XMLSchema#string

Wenjun Liang

http://www.w3.org/2001/XMLSchema#string

Yong Song

http://www.w3.org/2001/XMLSchema#string

P2860

Microtubules do not promote mitotic slippage when the spindle assembly checkpoint cannot be satisfied.

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

The meaning and use of the area under a receiver operating characteristic (ROC) curve

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer

Individual patient data meta-analysis of docetaxel administered once every 3 weeks compared with once every week second-line treatment of advanced non-small-cell lung cancer.

Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer.

Cisplatin plus gemcitabine versus a cisplatin-based triplet versus nonplatinum sequential doublets in advanced non-small-cell lung cancer: a Spanish Lung Cancer Group phase III randomized trial.

Weekly nab-paclitaxel in combination with carboplatin versus solvent-based paclitaxel plus carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer: final results of a phase III trial.

P304

632-639

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CRJ.12394

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26404101

http://www.w3.org/2001/XMLSchema#string

Assessing the clinical outcome of nab-paclitaxel in Chinese patients with advanced non-small-cell lung cancer.

about

P2860

P2860

Assessing the clinical outcome of nab-paclitaxel in Chinese patients with advanced non-small-cell lung cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698